1. Predictive value of vascular endothelial growth factor polymorphisms for maintenance bevacizumab efficacy in metastatic colorectal cancer: an ancillary study of the PRODIGE 9 phase III trial. (December 2022) Authors: de Rauglaudre, Bernadette; Sibertin-Blanc, Camille; Fabre, Aurélie; Le Malicot, Karine; Bennouna, Jaafar; Ghiringhelli, François; Taïeb, Julien; Boige, Valérie; Bouché, Olivier; Chatellier, Thierry; Faroux, Roger; François, Eric; Jacquot, Stéphane; Genet, Dominique; Mulot, Claire; Olschwang, Sylv... Journal: Therapeutic advances in medical oncology Issue: Volume 14(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗